1. Pink Sheet
  2. >>Compliance

More FDA Oversight Of DTC Ads May Be Needed To Curtail Misleading Claims, Study Argues

 
• By Jessica Merrill

Clearer US guidance on DTC TV advertising and stronger enforcement would help reduce misleading claims and encourage drug makers to include more qualitative benefit/risk information in ads, according to a new study from Yale University researchers published in the Journal of General Internal Medicine.

Researchers at Yale University advocated for more US FDA enforcement of direct-to-consumer (DTC) broadcast ads in a study published in the Journal of General Internal Medicine Feb. 26.

"It would be helpful if there were clearer and more detailed regulations and guidance for DTC broadcast ads, particularly with respect to providing quantitative risk information, along with better enforcement of current guidance," concluded the researchers

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance